The Canadian organization Crohn's and Colitis Canada announced that in 2014 alone they have already invested $3.4 million to support nine innovative research projects committed to finding the cure for Crohn's disease and ulcerative colitis, two debilitating chronic inflammatory bowel diseases.
All of the nine projects are currently being developed across Canada and studying the genetic and environmental causes of the diseases in order to improve the understanding and potential treatment of symptoms and develop innovations to improve patient care and quality of life. Crohn's and Colitis Canada helps the finest scientific minds find new approaches and treatments for the diseases by funding progressive and innovative projects.
"Crohn's and Colitis Canada is proud to fund and inspire the most promising research" said the Chief Executive Officer at Crohn's and Colitis Canada, Lindee David. "Our research investments are improving the lives of people affected by Crohn's and colitis, moving us forward to ultimately finding cures."
"Repairing damage to the intestinal lining is a key step to resolving inflammation in the gut. Our proposed studies will identify pathways that may be targets for new therapies to enhance healing in IBD patients," said Dr. Wallace MacNaughton, Professor and Head, Department of Physio